Get back to healthy, get back to happy

Get back to healthy, get back to happy

What we do

Seraphina Therapeutics advances nature and food-based science into evidence-driven consumer products that safely support healthier lives. As a company, we seek to advance products, starting with key fatty acids, that replenish micronutrients and metabolites that our bodies already have but increase in need, especially as we age.

Discover C15

C15:0 (aka pentadecanoic acid) is a trace odd-chain saturated fatty acid present in butter, whole milk, and some fish and plants. A growing body of global, scientific evidence supports C15:0 as a the first essential fatty acid to be discovered in 90 years. ​You’ve met omega-3 and omega-6. Now meet C15:0.

Discover C15

Fatty15

Fatty15 is the world’s first, and only science-backed, patented, award-winning C15:0 supplement that supports your long-term health & wellness.*

Fatty15

Who we are

We are a consortium of scientists, doctors, dreamers & innovators.​ We believe that if we can impact health at its core, we can change the world from the inside out.

Stephanie Venn-Watson

Stephanie Venn-Watson

DVM, MPH

Co-Founder, Chief Executive Officer

Steph is a serial entrepreneur of for-profit and not-for-profit companies, a veterinary epidemiologist and public health scientist with over 40 patents and 70 peer-reviewed scientific publications, and previously served as an epidemiologist tracking diseases for the Centers for Disease Control and Prevention and World Health Organization.

Eric Venn-Watson

Eric Venn-Watson

MD, MBA

Co-Founder, Chief Operating Officer

Eric is a practicing physician and entrepreneur. He served over 25 years as a Navy and Marine Corps physician, working with the special forces community to improve their health and fitness. Additionally, Eric founded multiple companies in the drug discovery, healthcare analytics, and medical device industries. He is passionate about developing medical technologies that improve the practice and delivery of healthcare on a global scale.

Kim Kamdar

Kim Kamdar

PhD

Co-Founder, Board Chair

Kim is a Managing Partner of Domain Associates, a life sciences venture capital firm, and has been involved in numerous cutting-edge therapeutic start-ups. She was also a research director at Novartis, where she led a team to uncover small molecules that modulated signaling pathway networks.

Nicholas Schork

Nicholas Schork

PhD

Co-Founder, Senior Scientist

Nicholas is a Distinguished Professor and Director of the Quantitative Medicine and Systems Biology Division at Translational Genomics Institute, an affiliate of The City of Hope. In addition, as a leader in the design and analysis of studies of longevity, Nicholas is Scientific Director for the National Institute of Health’s National Institute of Aging-sponsored Longevity Consortium.

Edward Dennis

Edward Dennis

PhD

Scientific Advisor

Ed is a Distinguished Professor of Chemistry, Biochemistry and Pharmacology specializing in lipid research at the University of California San Diego School of Medicine. Ed, who is a graduate of Yale University and Harvard University, was Editor-in-Chief of the Journal of Lipid Research and has 375 peer-reviewed publications, including roles of fatty acids in health.

Ronald Krauss

Ronald Krauss

MD

Scientific Advisor

Ron is a Senior Scientist and Director of Atherosclerosis Research at Children’s Hospital Oakland Research Institute and Adjunct Professor in the Department of Medicine at UCSF and the Department of Nutritional Sciences at UC Berkeley. Ron is a graduate of Harvard University, is board-certified in internal medicine, endocrinology and metabolism, and is a Fellow of the American Society of Nutrition and American Heart Association. He has 450 peer-reviewed publications, including leading papers on dairy-based fats and health.